BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10755370)

  • 1. Liquid chromatographic-electrospray tandem mass spectrometric method for the simultaneous quantitation of the prodrug fosinopril and the active drug fosinoprilat in human serum.
    Jemal M; Mulvana DE
    J Chromatogr B Biomed Sci Appl; 2000 Mar; 739(2):255-71. PubMed ID: 10755370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid chromatography/electrospray tandem mass spectrometry method for the quantitation of fosinoprilat in human serum using automated 96-well solid-phase extraction for sample preparation.
    Jemal M; Huang M; Mao Y; Whigan D; Schuster A
    Rapid Commun Mass Spectrom; 2000; 14(12):1023-8. PubMed ID: 10861982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of liquid chromatography-tandem mass spectrometric method for simultaneous determination of fosinopril and its active metabolite fosinoprilat in human plasma.
    Cui S; Feng F; Ma M; Liu H; Chen Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):143-51. PubMed ID: 17482898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous quantification of fosinopril and its active metabolite fosinoprilat in rat plasma by UFLC-MS/MS: Application of formic acid in the stabilization of an ester-containing drug.
    Xue K; Li G; Sun X; Hu Y; Hu L; Huang J; Si L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 May; 990():141-9. PubMed ID: 25875586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of liquid chromatographic method for fosinoprilat determination in human plasma using microemulsion as eluent.
    Jancic B; Ivanovic D; Medenica M; Malenovic A; Dimkovic N
    J Chromatogr A; 2005 Sep; 1088(1-2):187-92. PubMed ID: 16130750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sensitive and efficient LC-MS/MS method for the bioanalysis of fosinopril diacid from human plasma and its application for a bioequivalence study in humans.
    Bhende SD; Varanasi MB; Abbulu K
    Biomed Chromatogr; 2021 May; 35(5):e5047. PubMed ID: 33352616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of enalapril and enalaprilat in human plasma by liquid chromatography-tandem mass spectrometry.
    Gu Q; Chen X; Zhong D; Wang Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 813(1-2):337-42. PubMed ID: 15556550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative determination of pravastatin and its biotransformation products in human serum by turbo ion spray LC/MS/MS.
    Mulvana D; Jemal M; Pulver SC
    J Pharm Biomed Anal; 2000 Oct; 23(5):851-66. PubMed ID: 11022911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid chromatography/tandem mass spectrometry methods for quantitation of mevalonic acid in human plasma and urine: method validation, demonstration of using a surrogate analyte, and demonstration of unacceptable matrix effect in spite of use of a stable isotope analog internal standard.
    Jemal M; Schuster A; Whigan DB
    Rapid Commun Mass Spectrom; 2003; 17(15):1723-34. PubMed ID: 12872277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative liquid chromatographic-tandem mass spectrometric determination of reserpine in FVB/N mouse plasma using a "chelating" agent (disodium EDTA) for releasing protein-bound analytes during 96-well liquid-liquid extraction.
    Ke J; Yancey M; Zhang S; Lowes S; Henion J
    J Chromatogr B Biomed Sci Appl; 2000 Jun; 742(2):369-80. PubMed ID: 10901142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of a novel KDR kinase inhibitor and its N-oxide metabolite in human plasma using 96-well solid-phase extraction and liquid chromatography/tandem mass spectrometry.
    Xu Y; Du L; Soli ED; Braun MP; Dean DC; Musson DG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Mar; 817(2):287-96. PubMed ID: 15686997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming the stability, solubility and extraction challenges in reversed-phase UHPLC-MS/MS bioanalysis of a phosphate drug and its prodrug in blood lysate.
    Yuan L; Basdeo S; Ji QC
    J Pharm Biomed Anal; 2018 Aug; 157():36-43. PubMed ID: 29758468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of a selective adenosine 2A agonist, BMS-068645, and its acid metabolite in human plasma by liquid chromatography-tandem mass spectrometry--evaluation of the esterase inhibitor, diisopropyl fluorophosphate, in the stabilization of a labile ester-containing drug.
    Zeng J; Onthank D; Crane P; Unger S; Zheng N; Pasas-Farmer S; Arnold M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):77-84. PubMed ID: 17280881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of metabolites of fosinopril produced by human and rat liver microsomes with liquid chromatography-mass spectrometry.
    Uutela P; Monto M; Iso-Mustajärvi I; Madetoja M; Yliperttula M; Ketola RA
    Eur J Pharm Sci; 2014 Mar; 53():86-94. PubMed ID: 24365260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous assay of morphine, morphine-3-glucuronide and morphine-6-glucuronide in human plasma using normal-phase liquid chromatography-tandem mass spectrometry with a silica column and an aqueous organic mobile phase.
    Naidong W; Lee JW; Jiang X; Wehling M; Hulse JD; Lin PP
    J Chromatogr B Biomed Sci Appl; 1999 Dec; 735(2):255-69. PubMed ID: 10670739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of an LC-MS/MS method for the quantitative determination of aripiprazole and its main metabolite, OPC-14857, in human plasma.
    Kubo M; Mizooku Y; Hirao Y; Osumi T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Aug; 822(1-2):294-9. PubMed ID: 16005688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency.
    Greenbaum R; Zucchelli P; Caspi A; Nouriel H; Paz R; Sclarovsky S; O'Grady P; Yee KF; Liao WC; Mangold B
    Br J Clin Pharmacol; 2000 Jan; 49(1):23-31. PubMed ID: 10606834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of LTE4 in human urine by liquid chromatography coupled with ionspray tandem mass spectrometry.
    Wu Y; Li LY; Henion JD; Krol GJ
    J Mass Spectrom; 1996 Sep; 31(9):987-93. PubMed ID: 8831151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a selective and sensitive bioanalytical procedure for the quantitative determination of gaboxadol in human plasma employing mixed mode solid phase extraction and hydrophilic interaction liquid chromatography with tandem mass spectroscopic detection.
    Kall MA; Fu I; Dige T; Vallano P; Woolf E; Jørgensen M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):168-76. PubMed ID: 17851145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous determination of propranolol and 4-hydroxy propranolol in human plasma by solid phase extraction and liquid chromatography/electrospray tandem mass spectrometry.
    Partani P; Modhave Y; Gurule S; Khuroo A; Monif T
    J Pharm Biomed Anal; 2009 Dec; 50(5):966-76. PubMed ID: 19640669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.